CAS: 18043-71-5; 1,1,3,3-Tetraisopropyldisiloxane

该化合物是一种硅氧烷化合物,其独特结构由硅原子附着的四类异丙基类组成的硅氧烷脊椎组成,该化合物一般具有低挥发性和高热稳定性,适合化学和材料工业的各种应用,一般没有色素,其粘度较低,有助于其作为润滑剂或硅酮配方成分的用途;异丙基化合物的存在增强了其疏水性能,可以改善配方中的水抗药性.此外,1,1,3,3,3-乙基丙基丙基二醇烷与其他有机溶剂和聚合物可能表现出良好的兼容性,在涂料,密封剂和粘合剂的配方中具有价值.应当参考安全数据,以便处理和接触准则,如任何化学物质一样,确保在使用期间采取适当的安全措施.

结构式图片

相似化合物

67875-55-2 69304-37-6 36957-90-1

上下游产品

CAS号920-39-8 异丙基溴化镁 | CAS号75-26-3 2-溴丙烷 | CAS号69304-37-6 1,3二氯-1,1,3,3-四... | CAS号18173-84-7 hydroxy-di(prop... | CAS号1068-55-9 异丙基氯化镁 | CAS号2227-29-4 二异丙基氯代硅烷 | CAS号69304-37-6 1,3二氯-1,1,3,3-四...

合成工艺路线路线简述

    2,2,3,3-Tetraisopropyl-Oxadisilirane 反应生成1,1,3,3-四异丙基二硅氧烷
    参考文献:Peralkylated Four-And Five-Membered Cyclosilanes Containing A Heteroatom: Synthesis,Structure,And Properties
    标题:Peralkylated Four-And Five-Membered Cyclosilanes Containing A Heteroatom: Synthesis,Structure,And Properties
    摘要:
    Doi:10.1002/1099-0682(200207)2002:7<1772::Aid-Ejic1772>3.0.Co;2-F

    专利信息


    专利号:US-11542269-B2
    优先权日:2018-01-03
    标 题:Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
    发明人:CHOI HYEONG-WOOK; FANG FRANCIS G
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may be useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

    专利号:US-10913749-B2
    优先权日:2015-05-07
    标 题 :Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
    发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods for the synthesis of a halichondrin macrolides through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

    专利号:US-11136335-B2
    优先权日:2016-06-30
    标题:Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
    发明人:CHASE CHARLES E; CHOI HYEONG-WOOK; ENDO ATSUSHI; FANG FRANCIS G; KIM DAE-SHIK
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods for the synthesis of a halichondrin macrolides or analogs thereof through a cyclization reaction strategy. The strategy of the present invention involves subjecting an intermediate to Prins reaction conditions to afford a macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides or analogs thereof and methods for preparing the same.

    专利号:US-9783549-B2
    优先权日:2013-11-04
    标题:Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
    发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E; LEE JAEMOON
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Homer-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.

    专利号:US-9856276-B2
    优先权日:2010-01-26
    标 题:Compounds useful in the synthesis of halichondrin B analogs
    发明人:ENDO ATSUSHI; CHASE CHARLES E; FANG FRANCIS G
    权利人:EISAI R&D MAN CO LTD
    摘要:In general, the invention features compounds useful for the synthesis of analogs of halichondrin B, such as eribulin or pharmaceutically acceptable salts thereof, e.g., eribulin mesylate. Exemplary compounds are of formula (I), (II), or (III):

    专利号:US-7342003-B2
    优先权日:2001-10-25
    标 题 :Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
    发明人:MOORMAN ALLAN R; SCANNELL MICHAEL; BALASUBRAMANIAN THIAGARAJAN; OUTCALT RUSSELL; LEUNG EDWARD
    权利人:KING PHARMACEUTICALS RES & DEV
    摘要:Provided is a method for the synthesis of an aralkyloxyadenosine or an alkoxyadenosine. The method includes protecting the hydroxyl sugar groups with a protecting group to produce a protected halogenated adenosine. The protected halogenated adenosine is alkoxylated, and the hydroxyl sugar groups of the protected halogenated adenosine are deprotected to provide the aralkyloxyadenosine or alkoxyadenosine.
    南通嘉星泰生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jxtbio.com
    企业联系电话:18795782766;13773776703👤
    📞南通嘉星泰生物科技有限公司 ⚠️参考联系方式
    联系人:蔡先生
    电话:18795782766;13773776703

    传真:0513-87503981
    邮箱:297962169@qq.com
    通信地址: 江苏省如皋市石庄镇张扬园村十组42号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省如皋市石庄镇张扬园村十组42号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.carres.2012.03.016
    摘要:Johnsson R. Tetraisopropyldisiloxane-1,3-diyl as a versatile protecting group for pentopyranosides. Carbohydr Res. 2012 May 15;353():92–5. doi: 10.1016/j.carres.2012.03.016.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知